Please login to the form below
Random42 wins platinum award at the Creativity International Awards
Group also picks up a silver award for virtual reality
Random 42 has won a platinum award at this year’s Creativity International Awards for its ‘Defending Life: The Immune Ecosystem’ animation, which takes viewers on a journey through the body.
The scientific communications group also won a silver award for its ‘Iron Overload’ virtual reality programme.
That work, for Novartis, takes viewers inside the body to highlight the importance of iron maintenance.
The awards have been running annually since 1970 and among the 2017 winners were Hansei University’s Samsung Iris Medical Scanner, which picked up a silver award for ambient media.
Meanwhile, marketing group Sagon-Phior received a bronze award for its Clear ID website and McCann Torre Lazur accepted a silver award for its ‘Uptravi Stay Ahead Campaign’ and an additional silver award for its ‘Crohn’s disease convention booth’ animation.
The American Medical Association (AMA) also picked up two bronze awards for its website and blog.
1st June 2017
From:
Marketing
Share
Related Hub content
- Random42 Scientific Communication Win Telly Award for Medical Animation!
- Random42 Scientific Communication Win Creativity International Awards for Medical Animation and Scientific Virtual Reality
- Introducing the Newest Additions to Our Random42 Team!
- Random42 exhibiting at BIO-Europe 2018
- Random42 exhibiting at BIO International Convention 2019
Subscribe to our email news alerts
Featured jobs
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Roche’s Polivy recommended by NICE for lymphoma therapy
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- AbbVie’s Rinvoq approved by MHRA for Crohn's disease
- Eli Lilly announces $450m investment in US manufacturing site
- AstraZeneca’s Imfinzi plus chemotherapy approved by MHRA for biliary tract cancer
- ICR calls for improved biomarker cancer tests to help personalise treatment
- EIT Health marks World Cancer Day with €6m pledge for new healthcare delivery models
- World Cancer Day: encouraging men to put their health first
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Strategic behaviour
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- GSK to submit drug application for new antibiotic to US FDA
- EU outlines measures to mitigate antibiotic shortage across Europe
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- AbbVie’s Rinvoq approved by MHRA for Crohn's disease
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
PMHub
Evoke Mind+Matter
We are Evoke Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for...
Latest intelligence
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
- Pharmaceutical Marketing Strategies For The Digital Age
- In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...
